{"id":1773,"date":"2026-08-04T22:55:32","date_gmt":"2026-08-04T20:55:32","guid":{"rendered":"https:\/\/yanus.at\/?p=1773"},"modified":"2026-08-04T22:55:32","modified_gmt":"2026-08-04T20:55:32","slug":"boom-ul-biotehnologic-al-chinei-immunocan-asigura-250-milioane-de-yuan","status":"publish","type":"post","link":"https:\/\/yanus.at\/ro\/chinas-biotech-boom-immunocan-sichert-sich-250-millionen-yuan\/","title":{"rendered":"Boom-ul Biotech al Chinei: Immunocan asigur\u0103 250 de milioane de yuani"},"content":{"rendered":"

Compania de biotehnologie din Shanghai Immunocan a finalizat o rund\u0103 de finan\u021bare din seria A de 250 de milioane de yuani (aproximativ 32 de milioane de euro). Runda a fost condus\u0103 de investitorul american de s\u0103n\u0103tate Vivo Capital, cu participarea Gold Mine Multi Family Office \u0219i a investitorilor existen\u021bi Kingray Capital \u0219i TigerYeah Capital. Finan\u021barea urmeaz\u0103 s\u0103 accelereze dezvoltarea platformelor animalelor modificate genetic \u0219i s\u0103 aduc\u0103 pe pia\u021b\u0103 o platform\u0103 de iepuri cu anticorpi complet umani.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

Anticorpi din iepure<\/h3>\n\n\n\n

Immunocan s-a specializat \u00een dezvoltarea a\u0219a-numitelor platforme de descoperire a anticorpilor. Produsul principal: iepuri modifica\u021bi genetic, al c\u0103ror sistem imunitar produce anticorpi complet umani. Aceast\u0103 tehnologie ar putea accelera dezvoltarea unor noi medicamente, deoarece anticorpii ob\u021binu\u021bi sunt mai bine tolera\u021bi de corpul uman dec\u00e2t cei fabrica\u021bi \u00een mod conven\u021bional. Pentru industria farmaceutic\u0103, aceasta \u00eenseamn\u0103 poten\u021bial timpi mai scur\u021bi de dezvoltare \u0219i costuri mai mici \u00een c\u0103utarea de noi substan\u021be active \u00eempotriva cancerului, bolilor autoimune sau infec\u021biilor.<\/p>\n\n\n\n

Capitalul occidental \u00eent\u00e2lne\u0219te inova\u021bia chinez\u0103<\/h3>\n\n\n\n

Remarcabil \u00een runda de finan\u021bare este compozi\u021bia investitorilor. Cu Vivo Capital intr\u0103 un fond american de s\u0103n\u0103tate bine stabilit, care gestioneaz\u0103 peste 20 de miliarde de dolari la nivel mondial. Acest lucru se \u00eent\u00e2mpl\u0103 \u00eentr-un moment \u00een care tensiunile geopolitice dintre Washington \u0219i Beijing se intensific\u0103 \u00een special \u00een sectorul tehnologic. Se pare c\u0103 investitorii occidentali continu\u0103 s\u0103 vad\u0103 oportunit\u0103\u021bi \u00een sectorul biotehnologic chinez care dep\u0103\u0219esc riscul politic. Pentru startup-urile chineze, la r\u00e2ndul lor, capitalul interna\u021bional r\u0103m\u00e2ne un semnal important pentru calitate \u0219i credibilitate pe pia\u021ba mondial\u0103.<\/p>\n\n\n\n

Ce \u00eenseamn\u0103 asta pentru Austria?<\/h3>\n\n\n\n

Industria farmaceutic\u0103 \u0219i institu\u021biile de cercetare austriace observ\u0103 cu aten\u021bie dezvolt\u0103rile chineze. <\/p>\n\n\n\n

Companii interne precum Boehringer Ingelheim cu sediul s\u0103u la Viena sau numeroasele startup-uri de biotehnologie din jurul universit\u0103\u021bilor ar putea activa \u00een viitor at\u00e2t ca clien\u021bi, c\u00e2t \u0219i ca concuren\u021bi ai platformelor precum Immunocan. Tehnologia modelelor animalelor modificate genetic este, de asemenea, un domeniu activ de cercetare \u00een Europa. <\/p>\n\n\n\n

Progresele chineze m\u0103resc presiunea competitiv\u0103, dar ar putea deschide \u0219i posibilit\u0103\u021bi de cooperare, de exemplu \u00een domeniul cercet\u0103rii preclinice.<\/p>\n\n\n\n

Cele dou\u0103 fe\u021be ale puterii<\/h3>\n\n\n\n

Sectorul biotehnologic al Chinei cre\u0219te rapid cu sprijinul statului \u0219i capitalul interna\u021bional. Aceasta deschide oportunit\u0103\u021bi: dezvoltare mai rapid\u0103 a medicamentelor, noi terapii, parteneriate globale. \u00cen acela\u0219i timp, platformele animalelor modificate genetic ridic\u0103 \u00eentreb\u0103ri etice, care sunt reglementate mai strict \u00een Europa dec\u00e2t \u00een China. \u00cen plus, r\u0103m\u00e2ne neclar cum vor afecta controalele de export \u0219i investi\u021bii mai stricte colaborarea. Pentru actorii austrieci, este important s\u0103 monitorizeze cu aten\u021bie dezvolt\u0103rile tehnologice, f\u0103r\u0103 euforie naiv\u0103 sau respingere generalizat\u0103.<\/p>\n\n\n\n

Surs\u0103: TechNode | Articolul original<\/a><\/em><\/p>","protected":false},"excerpt":{"rendered":"

Specialistul \u00een anticorpi din Shanghai prime\u0219te o injec\u021bie masiv\u0103 de finan\u021bare pentru platforme animale modificate genetic. Investitorii occidentali \u0219i chinezi pariaz\u0103 \u00eempreun\u0103 pe viitorul dezvolt\u0103rii medicamentelor.<\/p>","protected":false},"author":3,"featured_media":1772,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"colormag_page_container_layout":"default_layout","colormag_page_sidebar_layout":"default_layout","_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"{title}\n\n{excerpt}\n\nMehr lesen: {url}\n\n{tags}\n#YANUS","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"_wpas_customize_per_network":false},"categories":[47,31,20],"tags":[],"class_list":["post-1773","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-china-asien","category-tech","category-wirtschaft"],"jetpack_publicize_connections":[],"jetpack_likes_enabled":true,"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/yanus.at\/wp-content\/uploads\/2026\/05\/pixabay_5501210.jpg","_links":{"self":[{"href":"https:\/\/yanus.at\/ro\/wp-json\/wp\/v2\/posts\/1773","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/yanus.at\/ro\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/yanus.at\/ro\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/yanus.at\/ro\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/yanus.at\/ro\/wp-json\/wp\/v2\/comments?post=1773"}],"version-history":[{"count":2,"href":"https:\/\/yanus.at\/ro\/wp-json\/wp\/v2\/posts\/1773\/revisions"}],"predecessor-version":[{"id":3436,"href":"https:\/\/yanus.at\/ro\/wp-json\/wp\/v2\/posts\/1773\/revisions\/3436"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/yanus.at\/ro\/wp-json\/wp\/v2\/media\/1772"}],"wp:attachment":[{"href":"https:\/\/yanus.at\/ro\/wp-json\/wp\/v2\/media?parent=1773"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/yanus.at\/ro\/wp-json\/wp\/v2\/categories?post=1773"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/yanus.at\/ro\/wp-json\/wp\/v2\/tags?post=1773"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}